These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 18982740

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia].
    Kolovrat A, Jurisić I, Marić Z, Cvitković A.
    Acta Med Croatica; 2010 Oct; 64(4):287-96. PubMed ID: 21688612
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C prevalence and risk behavior of injecting drug users in Sydney: a continuing concern.
    Habib SE, Lovejoy FH, Aspin C.
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):823-34. PubMed ID: 12041560
    [Abstract] [Full Text] [Related]

  • 4. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B, Narayanan S, Navaratnam V.
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
    Smyth BP, Barry J, Keenan E.
    Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
    [Abstract] [Full Text] [Related]

  • 7. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R, Miller J, Lungley S, Baker M.
    N Z Med J; 1998 Feb 27; 111(1060):50-3. PubMed ID: 9539916
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users.
    Robinson GM, Reynolds JN, Robinson BJ.
    N Z Med J; 1995 Mar 22; 108(996):103-5. PubMed ID: 7715873
    [Abstract] [Full Text] [Related]

  • 9. Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden.
    Norden L, Saxon L, Kåberg M, Käll K, Franck J, Lidman C.
    Scand J Infect Dis; 2009 Mar 22; 41(10):727-34. PubMed ID: 19688640
    [Abstract] [Full Text] [Related]

  • 10. High prevalence of HCV in a cohort of injectors on methadone substitution treatment.
    Lee KC, Lim WW, Lee SS.
    J Clin Virol; 2008 Apr 22; 41(4):297-300. PubMed ID: 18191614
    [Abstract] [Full Text] [Related]

  • 11. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
    Miller CL, Johnston C, Spittal PM, Li K, Laliberté N, Montaner JS, Schechter MT.
    Hepatology; 2002 Sep 22; 36(3):737-42. PubMed ID: 12198668
    [Abstract] [Full Text] [Related]

  • 12. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L, Li J, Jalaludin B, Wand H, Jayasuriya R, Dixon D, Kaldor JM.
    Drug Alcohol Depend; 2007 Jul 10; 89(2-3):244-50. PubMed ID: 17289299
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
    Badridze N, Chkhartishvili N, Abutidze A, Gatserelia L, Sharvadze L.
    Georgian Med News; 2008 Dec 10; (165):54-60. PubMed ID: 19124918
    [Abstract] [Full Text] [Related]

  • 15. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
    Quaglio G, Lugoboni F, Pajusco B, Sarti M, Talamini G, Lechi A, Mezzelani P, Des Jarlais DC.
    Clin Infect Dis; 2003 Jul 01; 37(1):33-40. PubMed ID: 12830406
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities.
    Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM, Kapadia F, Garfein RS, DUIT Study Team.
    Drug Alcohol Depend; 2007 Nov 01; 91 Suppl 1():S39-47. PubMed ID: 17466464
    [Abstract] [Full Text] [Related]

  • 19. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
    Oliveira Mde L, Bastos FI, Telles PR, Hacker Mde A, Oliveira SA, Miguel JC, Yoshida CF.
    J Clin Virol; 2009 Mar 01; 44(3):200-6. PubMed ID: 19195927
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience.
    Roy E, Boudreau JF, Boivin JF.
    Drug Alcohol Depend; 2009 Jun 01; 102(1-3):158-61. PubMed ID: 19251382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.